Clinical Scorecard: New AAP Guidelines Address Pediatric Opioid Prescribing
At a Glance
| Category | Detail |
|---|---|
| Condition | Pediatric Opioid Prescribing |
| Key Mechanisms | Multimodal pain management, nonpharmacologic therapies, and nonopioid medications. |
| Target Population | Children and adolescents in outpatient settings. |
| Care Setting | Outpatient clinical practice. |
Key Highlights
- Avoid opioid monotherapy for acute pain.
- Prescribe immediate-release opioids at the lowest effective dose for 5 days or fewer.
- Do not prescribe codeine or tramadol for children under 12.
- Provide naloxone and educate caregivers on overdose recognition.
- Implement clinical decision support tools in electronic health records.
Guideline-Based Recommendations
Diagnosis
- Assess pain severity and consider multimodal approaches.
Management
- Incorporate nonpharmacologic therapies and nonopioid medications.
- Exercise caution when prescribing to patients on sedating medications.
Monitoring & Follow-up
- Monitor opioid prescribing metrics to address health equity.
Risks
- Avoid abrupt discontinuation of long-term opioid therapy to prevent adverse outcomes.
Patient & Prescribing Data
Adolescents aged 15-19 years and children under 18.
Pediatric opioid prescribing rates have decreased, but may include both appropriate and inappropriate reductions.
Clinical Best Practices
- Educate caregivers about safe storage, administration, and disposal of opioids.
- Partner with other clinicians for managing acute pain in patients with chronic pain.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
